Inspire Medical Systems, Inc. Q2 2026 Earnings Recap

Inspire Medical Systems shares surged 27.7% following Q2 results as the company raised full-year guidance on revenue, adjusted operating margin, and adjusted EPS, driven by improved coding clarity and reimbursement initiatives that buoyed investor confidence.

Key Takeaways

• Q2 adjusted operating income and positive cash flow came in ahead of expectations due to disciplined cost management.
• Company highlighted improved prior authorization submissions and clearer coding guidance for the Inspire V system, reducing payer confusion.
• CMS has proposed 12% and 15% increases in 2027 hospital outpatient and ASC reimbursement rates respectively for Inspire V procedures.
• Despite a 4% proposed decrease in physician reimbursement, management is advancing efforts to secure a new Category 1 CPT code for a single lead Inspire system, with approval expected in September.
• The new Project Horizon strategic growth plan aims to accelerate revenue growth by investing $30 million annually to optimize patient flow, organizational structure, and supply chain efficiencies.